Monocyte chemoattractant protein-1 (MCP-1/CCL2) is a key chemokine that regulates monocyte and macrophage migration and infiltration. It belongs to the C-C chemokine family and is involved in various diseases, including HIV-1 infection, atherosclerosis, cancer, and autoimmune disorders. CCL2 is produced by multiple cell types and plays a critical role in immune surveillance and inflammation. It binds to its receptor, CCR2, which is expressed on various leukocytes. CCL2 is involved in the recruitment of monocytes, memory T cells, and natural killer cells. It also influences T-cell immunity by promoting Th2 responses and IL-4 secretion. CCL2 is implicated in the pathogenesis of several diseases, including HIV-1, where it contributes to viral spread and disease progression. Genetic variations in CCL2 are associated with increased risk of cardiovascular disease, multiple sclerosis, and other conditions. CCL2 also plays a role in cancer by promoting tumor growth and angiogenesis. In addition, CCL2 is involved in neurological disorders, such as Alzheimer's disease, where it may contribute to neuronal death. Despite its role in disease, CCL2 is essential for immune function and maintaining health. Research on CCL2 and its receptor CCR2 is ongoing, with potential therapeutic strategies targeting these pathways for the treatment of various diseases.Monocyte chemoattractant protein-1 (MCP-1/CCL2) is a key chemokine that regulates monocyte and macrophage migration and infiltration. It belongs to the C-C chemokine family and is involved in various diseases, including HIV-1 infection, atherosclerosis, cancer, and autoimmune disorders. CCL2 is produced by multiple cell types and plays a critical role in immune surveillance and inflammation. It binds to its receptor, CCR2, which is expressed on various leukocytes. CCL2 is involved in the recruitment of monocytes, memory T cells, and natural killer cells. It also influences T-cell immunity by promoting Th2 responses and IL-4 secretion. CCL2 is implicated in the pathogenesis of several diseases, including HIV-1, where it contributes to viral spread and disease progression. Genetic variations in CCL2 are associated with increased risk of cardiovascular disease, multiple sclerosis, and other conditions. CCL2 also plays a role in cancer by promoting tumor growth and angiogenesis. In addition, CCL2 is involved in neurological disorders, such as Alzheimer's disease, where it may contribute to neuronal death. Despite its role in disease, CCL2 is essential for immune function and maintaining health. Research on CCL2 and its receptor CCR2 is ongoing, with potential therapeutic strategies targeting these pathways for the treatment of various diseases.